Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

FRF, PWRM, PGH, ORFG, NOK - Stock Update From DrStockPick.com!

<p> </p>
<p align="center"><a title="hot stock alerts, hottest stock picks, best stock picks, hot stock picks" href="drstockpick.com/?page_id=3098&quot;><img alt="drstock-2-3" src="crownequityholdings.com/img/drstock-2-3....; width="98" height="34" /></a></p>
<p align="center"><a title="hot stock alerts, hot stock picks" href="drstockpick.com/?page_id=3098&quot;><img alt="signup3m" src="drstockpick.com/img/signup3m.gif&quot; width="360" height="50" /></a></p>
<p><br />
<a title="Penny stocks, hot stocks, free stock alerts, microcap stocks, penny stocks, pennystocks, best penny stocks, penny stock, pennystock, hot penny stock, list of penny stocks, top pennystocks, free penny stock alerts" href="www.Power3Medical.com&quot;><img style="WIDTH: 132px; HEIGHT: 57px" alt="power3" src="pennyomega.com/img/power3.png&quot; width="152" height="63" /></a></p>
<p><strong>Power3 Medical Products, Inc. (OTC.BB:PWRM)</strong> a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer's and Parkinson's, to name a few.</p>
<p>"We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now," stated Ira L. Goldknopf, President and Chief Scientific Officer of <strong>Power3 Medical Products, Inc</strong>. "We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for <strong>Power3</strong> is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger."</p>
<p>Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. <strong>Power3</strong> plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into <strong>Power3,</strong> with <strong>Power3</strong> remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.</p>
<p><strong>Power3 Medical Products, Inc</strong>. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). <strong>Power3</strong> applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, <strong>Power3</strong> has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials.</p>
<p align="center"> </p>
<p align="center"> </p>
<p align="center"> </p>
<p align="center"> </p>
<p align="center"><a title="hot stock alerts, hottest stock picks, best stock picks, hot stock picks" href="drstockpick.com/?page_id=3098&quot;></a></p>
<p align="center"><a title="hot stock alerts, hot stock picks" href="drstockpick.com/?page_id=3098&quot;></a></p>
<p>***********************************************</p>
<p><a href="www.orofinogold.com/&quot; target="_blank"><img class="alignnone size-full wp-image-5182" title="orfg_logo203x87" alt="orfg_logo203x87" src="bestotc.com/img/orfgx.png&quot; width="185" height="79" /></a></p>
<p><strong>Orofino Gold Corp. (ORFG.PK)</strong> is a China based gold producer with one producing gold mine in Colombia and an option on a strong portfolio of small producers and development/exploration assets in Colombia.</p>
<p><strong>Orofino Gold</strong> was founded as a private company in 2009 by former executives and management with over 50 years of combined mining exploration, finance and development experience.</p>
<p><strong>Orofino's</strong> corporate objective is to continue to build shareholder value through the exploration and development of existing projects and additional accretive acquisitions, capitalizing on the extensive experience and relationships that management has developed over the past 25 years.</p>
<p>La Azul is one producing artesanal mine in the Senderos de Oro area controlled by <strong>Orofino</strong>, it is a mixed sequence of predominantly volcanic rocks with the vien systems comprised of high grade chalcopyrite, galena and sphalerite with pyrite in quartz viens.</p>
<p>It has been interpreted (by Shaw 1993) that the metallogenic zonation around the La Azul workings evokes a very viable "hidden porphyry" exploration model. This interpretation and the prospectivity of the area have been confirmed by the Orofino "qualified person" as per the 43-101 rules.</p>
<p><strong>Orofino</strong> will move ahead aggressively in the last quarter of 2010 to persue the current interpretations, work programs and drilling will begin soon.</p>
<p>The observed metallogenic zonation around Senderos de Oro evokes a very viable "hidden porphyry" exploration model. Based upon exploration carried out to date, it is clear that the area hosts significant resources of gold, copper and silver, which, facilitated by the current database and favorable topography, has generated excellent "fast-trackable" bulk-tonnage or high-grade underground Au-Ag-Cu exploration targets.</p>
<p>***********************************************</p>
<p><strong>Nokia Corporation (NYSE:NOK)</strong> third-quarter 2010 net sales increased 5% to EUR 10.3 billion, compared with EUR 9.8 billion in the third quarter 2009, and increased 3% compared with EUR 10.0 billion in the second quarter 2010. At constant currency, group net sales would have decreased 2% year-on-year and increased 1% sequentially."</p>
<p><strong>Nokia Corporation</strong> manufactures and sells mobile devices, and provides Internet and digital mapping and navigation services worldwide. Its Devices &amp; Services segment develops and manages a portfolio of mobile devices, such as mobile phones, smart phones, and mobile computers; services; applications; and content.</p>
<p>***********************************************</p>
<p><strong>Pengrowth Energy Trust (PGH) (NYSE:PGH)</strong> announced the results of the special meeting of unitholders. At this morning’s special meeting, holders of <strong>Pengrowth</strong> trust units and <strong>Pengrowth</strong> exchangeable shares overwhelmingly approved the proposed conversion (the “Conversion”) of <strong>Pengrowth Energy Trust</strong> from an income trust to a corporation to be named <strong>Pengrowth Energy</strong> Corporation. Securityholders voted 99 percent in favour of the Conversion. The Conversion remains subject to approval of the Court of Queen’s Bench of Alberta which will be sought on December 17, 2010. Assuming that court approval is received, the Conversion is expected to close on December 31, 2010.</p>
<p><strong>Pengrowth Energy Trust</strong> operates as an energy investment trust in Canada. The company, through its subsidiary, <strong>Pengrowth</strong> Corporation, engages in the acquisition, ownership, and operation of working and royalty interests in oil and natural gas properties primarily in the Western Canadian Sedimentary Basin.</p>
<p>***********************************************</p>
<p><strong>FORTEGRA FINANCIAL CORP. (NYSE:FRF)</strong> announced the pricing of its initial public offering of 6,000,000 shares of the Company’s common stock at $11.00 per share. The shares began trading on December 17, 2010 on the New York Stock Exchange under the symbol “<strong>FRF</strong>”.</p>
<p><strong>Fortegra Financial Corporation</strong>, an insurance services company, provides insurance-related products and distribution and administration services in the United States. Its Payment Protection segment offers a range of regulated insurance products, including credit property, credit life, and credit disability.</p>
<p align="center">******************************************************************************</p>
<p style="TEXT-ALIGN: center"><a href="stock-ir.com/campaign/marketing.pdf&quot;></a></p>
<p align="center"> </p>
<p align="center"> </p>
<p align="center"><strong>THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!</strong></p>
<p align="center"><a href="stock-ir.com/campaign/marketing.pdf&quot;><img alt="drstbc" src="pennyomega.com/img/drstbc.jpg&quot; width="360" height="144" /></a></p>
<p style="TEXT-ALIGN: left"><a href="crownequityholdings.com/disclaimer.html&quot;><strong><font color="red">Disclaim</font></strong></a><a href="crownequityholdings.com/disclaimer.html&quot;><font color="red">er:</font></a> <font color="navy">Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.</font> <font color="red"><strong>(Read more at</strong></font> <a href="drstockpick.com/disclaimer&quot;><strong><font color="red">drstockpick.com/disclaimer&lt;/font></strong></a><font color="navy"><font color="red"><strong>)</strong></font> .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.</font></p>
<p style="TEXT-ALIGN: left"><font color="red"><strong>Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).</strong></font></p>
<p><font color="navy"><strong><font color="red">Crown Equity Holdings Inc. (OTCPK:CRWE) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising</font></strong> .</font></p>